Metronidazole
Brand name: Metronidazole
Rank #440 of 500 drugs by total cost
$18.0M
Total Cost
405,967
Total Claims
$18.0M
Total Cost
17,762
Prescribers
$44
Cost per Claim
241,007
Beneficiaries
430,858
30-Day Fills
$1,015
Avg Cost/Provider
23
Avg Claims/Provider
About Metronidazole
Metronidazole (sold as Metronidazole) was prescribed 405,967 times by 17,762 Medicare Part D providers in 2023, costing the program $18.0M. At $44 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 437 | Sacrosidase (Sucraid) | $18.5M | 1,517 |
| 438 | Enasidenib Mesylate (Idhifa) | $18.1M | 554 |
| 439 | Posaconazole (Posaconazole) | $18.0M | 7,163 |
| 440 | Metronidazole (Metronidazole) | $18.0M | 405,967 |
| 441 | Rufinamide (Rufinamide) | $18.0M | 8,793 |
| 442 | Istradefylline (Nourianz) | $17.8M | 7,061 |
| 443 | Encorafenib (Braftovi) | $17.6M | 1,209 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology